OneFund LLC’s Gilead Sciences GILD Stock Holding History

OneFund LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$428K	Sell	3,384 -26	-0.8%	-$3.43K	0.24%	76
2026 Q1	$478K	Sell	3,410 -142	-4%	-$19.9K	0.31%	59
2025 Q4	$436K	Buy	3,552 +201	+6%	+$24.4K	0.26%	73
2025 Q3	$372K	Buy	3,351 +122	+4%	+$13.9K	0.24%	81
2025 Q2	$358K	Sell	3,229 -23	-0.7%	-$2.45K	0.26%	74
2025 Q1	$364K	Sell	3,252 -43	-1%	-$4.44K	0.37%	69
2024 Q4	$304K	Buy	3,295 +27	+0.8%	+$2.43K	0.29%	82
2024 Q3	$274K	Buy	3,268 +13	+0.4%	+$992	0.28%	96
2024 Q2	$223K	Buy	3,255 +48	+1%	+$3.2K	0.24%	106
2024 Q1	$234K	Sell	3,207 -87	-3%	-$6.69K	0.28%	102
2023 Q4	$267K	Buy	+3,294	New	+$256K	0.35%	86

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OneFund LLC's GILD Position: Q2 2026 in Review

OneFund LLC reduced its Gilead Sciences (GILD) stake by 0.76% in Q2 2026, selling an estimated $3.43K and leaving 3,384 shares worth $428K. The position accounts for 0.24% of the portfolio, ranked #76.

OneFund LLC first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $478K in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

OneFund LLC held 3,384 shares of Gilead Sciences worth $428K as of Q2 2026.
OneFund LLC sold 26 Gilead Sciences shares in Q2 2026, an estimated $3.43K.
Gilead Sciences made up 0.24% of OneFund LLC's portfolio in Q2 2026, its #76 holding.
OneFund LLC first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
OneFund LLC's Gilead Sciences position peaked at $478K in Q1 2026.
2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on OneFund LLC's 13F filing for Q2 2026, filed 24 Aug 2026.